Moderna, Inc.MRNANASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank44
3Y CAGR+16.3%
5Y CAGR-34.7%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+16.3%/yr
vs -43.6%/yr prior
5Y CAGR
-34.7%/yr
Recent acceleration
Acceleration
+60.0pp
Accelerating
Percentile
P44
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.90 | +18.2% |
| 2024 | 4.99 | -10.0% |
| 2023 | 5.55 | +48.0% |
| 2022 | 3.75 | -35.0% |
| 2021 | 5.77 | -88.4% |
| 2020 | 49.59 | -53.9% |
| 2019 | 107.47 | +189.1% |
| 2018 | 37.17 | +9.4% |
| 2017 | 33.98 | +208.9% |
| 2016 | 11.00 | - |